Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:CBMG

Cellular Biomedicine Group (CBMG) Stock Price, News & Analysis

Cellular Biomedicine Group logo

About Cellular Biomedicine Group Stock (NASDAQ:CBMG)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$17.67
$19.75
52-Week Range
N/A
Volume
8,375 shs
Average Volume
129,776 shs
Market Capitalization
$384.69 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive CBMG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cellular Biomedicine Group and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

CBMG Stock News Headlines

Forget AI Stocks — This Device Will REPLACE the Microchip
While everyone's chasing the same AI plays, George Gilder is focused on something completely different. He says a 4-nanometer device that's 80 MILLION times more powerful than the chip he gave Reagan is now being made in America for the first time. And he's identified 3 companies that control this technology.tc pixel
See More Headlines

CBMG Stock Analysis - Frequently Asked Questions

Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) released its earnings results on Monday, November, 9th. The biotechnology company reported ($0.88) earnings per share for the quarter, missing the consensus estimate of ($0.63) by $0.25. The biotechnology company earned $0.03 million during the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cellular Biomedicine Group investors own include CRISPR Therapeutics (CRSP), Anavex Life Sciences (AVXL), Aduro Biotech (ADRO), Allena Pharmaceuticals (ALNA), Amarin (AMRN), Bristol Myers Squibb (BMY) and Intellia Therapeutics (NTLA).

Company Calendar

Last Earnings
11/09/2020
Today
9/16/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Biological Products, Except Diagnostic
Sub-Industry
N/A
Current Symbol
NASDAQ:CBMG
CIK
1378624
Fax
N/A
Employees
217
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$49.98 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-144.80%
Return on Assets
-61.68%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.47
Quick Ratio
0.47

Sales & Book Value

Annual Sales
$340 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$2.89 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
19,478,000
Free Float
N/A
Market Cap
$384.69 million
Optionable
Optionable
Beta
1.35
 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report

This page (NASDAQ:CBMG) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners